首页 | 本学科首页   官方微博 | 高级检索  
检索        

磷脂酰肌醇蛋白多糖3对胆道闭锁患儿的诊断价值及与肝纤维化的关系
引用本文:陈灵芝,詹江华,赵金凤,杨芳,赵一霖,林书祥,马慧,胡晓丽.磷脂酰肌醇蛋白多糖3对胆道闭锁患儿的诊断价值及与肝纤维化的关系[J].天津医药,2022,50(1):15-19.
作者姓名:陈灵芝  詹江华  赵金凤  杨芳  赵一霖  林书祥  马慧  胡晓丽
作者单位:1天津医科大学研究生院(邮编300070);2天津市儿童医院普外科,3儿科研究所,4检验科,5病理科
基金项目:新疆维吾尔自治区自然科学基金(2019D01A12);
摘    要:摘要:目的 探讨磷脂酰肌醇蛋白多糖3(GPC3)在胆道闭锁(BA)患儿中表达水平及其与肝纤维化的关系。方法 收集BA患儿41例(BA组)、胆总管囊肿(CC)患儿9例(CC组)、肝功能正常无其他肝胆疾病的体检健康婴儿12例(NC组)。用酶联免疫吸附试验(ELISA)检测3组血清GPC3水平,使用受试者工作特征(ROC)曲线评估GPC3对BA的辅助诊断价值。留取BA组和CC组肝组织样本,通过免疫组织化学染色和实时荧光定量PCR检测GPC3在患儿肝组织中表达水平,分析BA患儿GPC3与肝纤维化分级的关系。结果 (1)BA组GPC3水平高于CC组和NC组(χ2=24.170,P<0.01)。BA组内日龄≤30 d(21例)及>30 d的患儿(20例)血清GPC3水平差异无统计学意义,但均高于CC组和NC组(χ2=24.210,P<0.01)。BA组内Ⅰ~Ⅱ级与Ⅲ~Ⅳ级患儿GPC3水平差异无统计学意义,但均高于CC组和NC组(χ2=24.390,P<0.01)。GPC3诊断BA的ROC曲线下面积为0.878(95%CI:0.792~0.965,P<0.01),敏感度为82.93%,特异度为80.95%,最佳临界值为0.639 μg/L。(2)肝组织免疫组织化学检测结果显示,BA组肝组织中GPC3表达较CC组明显升高(Z=3.565,P<0.01);肝组织中GPC3的含量与肝纤维化分级呈正相关(rs=0.619,P<0.01)。BA组GPC3 mRNA表达较CC组上调(Z=7.361,P<0.05)。结论 血清GPC3对BA的诊断及鉴别诊断有一定临床价值;BA肝组织中GPC3表达上调,其表达量与胆道闭锁的肝纤维化分级呈正相关。

关 键 词:胆道闭锁  肝硬化  磷脂酰肌醇蛋白聚糖类  诊断  磷脂酰肌醇蛋白多糖3  
收稿时间:2021-05-12
修稿时间:2021-09-25

The diagnostic value of glypican 3 in children with biliary atresia and its relationship withliver fibrosis#br#
CHEN Lingzhi,ZHAN Jianghua△,ZHAO Jinfeng,YANG Fang,ZHAO Yilin,LIN Shuxiang,MA Hui,HU Xiaoli.The diagnostic value of glypican 3 in children with biliary atresia and its relationship withliver fibrosis#br#[J].Tianjin Medical Journal,2022,50(1):15-19.
Authors:CHEN Lingzhi  ZHAN Jianghua△  ZHAO Jinfeng  YANG Fang  ZHAO Yilin  LIN Shuxiang  MA Hui  HU Xiaoli
Institution:1 Graduate School, Tianjin Medical University, Tianjin 300070, China; 2 Department of Pediatric Surgery, 3 Department of Pediatric Research Institute, 4 Department of Laboratory Medicine, 5 Department of Pathology, Tianjin Children's Hospital
Abstract:Abtract: Objective To investigate the expression levels of glypican 3 (GPC3) and its association with liver fibrosis in children with biliary atresia (BA). Methods A total of 41 infants with BA (BA group), 9 infants with choledochal cyst (CC group) and 12 healthy infants with normal liver function and no other hepatobiliary diseases by physical examination (NC group) were collected. Serum GPC3 levels were measured by enzyme-linked immunosorbent assay (ELISA) in the 3 groups. The receiver operating characteristic (ROC) curve was used to evaluate the auxiliary diagnostic value of GPC3 for BA. Liver tissue samples from the BA group and the CC group were retained to analyze the relationship between GPC3 and the grade of liver fibrosis in children with BA by measuring the expression levels of GPC3 by immunohistochemical staining and qPCR. Results (1) GPC3 levels were significantly higher in the BA group than those in the CC group and the NC group (χ2=24.170, P<0.01). There were no significant differences in the serum levels of GPC3 in children aged≤30 d (n = 21) and children aged>30 d (n = 20) in the BA group, but which were higher than those in the CC group and the NC group (χ2=24.210, P<0.01). There were no significant differences in GPC3 levels between grades Ⅰ to Ⅱ and grades Ⅲ to Ⅳ children in the BA group, but which were higher than those in the CC group and the NC group (χ2=24.390, P<0.01). The area under the ROC curve (AUC) of GPC3 for the diagnosis of BA was 0.878 (95%CI: 0.792-0.965, P<0.01), with a sensitivity of 82.93%, a specificity of 80.95%, and an optimal cut-off value of 0.639 μg/L. (2) The results of liver tissueimmunohistochemistry showed that GPC3 expression in liver tissue was significantly increased in the BA group compared to that of the CC group (Z=3.565, P<0.01), and the content of GPC3 in liver tissue was positively correlated with the grade of liver fibrosis (rs=0.619, P<0.01). The GPC3 expression was upregulated in the BA group compared to that of the CC group (Z=7.361, P<0.05). Conclusion The serum GPC3 has clinical value in the diagnosis and differential diagnosis of BA. GPC3 expression is upregulated in BA liver tissue, and its expression level is positively correlated with the grade of liver fibrosis in biliary atresia.
Keywords:biliary atresia  liver cirrhosis  glypicans  diagnosis  glypican 3  
点击此处可从《天津医药》浏览原始摘要信息
点击此处可从《天津医药》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号